Botanix Pharmaceuticals Ltd Long-term Investment Intensity

Latest as of June 2022: 0.4%

Botanix Pharmaceuticals Ltd long-term investment intensity. Botanix Pharmaceuticals Ltd (BOT) has a Long-term Investment Intensity of 0.4% as of June 2022. Long-term investments of AU$61.71K represent 0.4% of total assets of AU$14.04 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read BOT total liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

0.4%
LT Investments / Total Assets

Long-term Investments

AU$61.71K
AUD

Total Assets

AU$14.04 Million
AUD

Country

Australia
AU

Long-term Investment Intensity of Botanix Pharmaceuticals Ltd (2020–2022)

Long-term investment intensity of Botanix Pharmaceuticals Ltd from 2020 to 2022. This chart shows how Botanix Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2022, the intensity stands at 0.4%, reflecting long-term investments of AU$61.71K against total assets of AU$14.04 Million AUD.

Botanix Pharmaceuticals Ltd Long-term Investment Intensity by Year (2020–2022)

Botanix Pharmaceuticals Ltd long-term investment intensity by year from 2020 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Botanix Pharmaceuticals Ltd from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BOT asset base.

Year LT Investment Intensity LT Investments (AUD) Total Assets Change (pp)
2022 0.4% AU$61.71K AU$14.04 Million ▲ +0.2 pp
2021 0.3% AU$62.37K AU$21.95 Million ▼ -0.1 pp
2020 0.4% AU$88.73K AU$25.31 Million —
pp = percentage points